Meeting
Abstract Number: 308
SHM Converge 2024
Background: Guidelines for inpatient diabetes management recommend insulin therapy for persistent hyperglycemia >180 mg/dL with a target glucose range of 140 – 180 mg/dL.1,2 Although guidelines recommend glucose monitoring for insulin administration, there is no standard monitoring approach for patients without evidence of persistent hyperglycemia. As such, hospitalized patients are frequently started on 3 – […]
Abstract Number: 406
SHM Converge 2024
Background: Urine culture testing should primarily be reserved for patients with clinical symptoms or other limited indications. Unfortunately, many admitted patients undergo unnecessary urine culture testing, leading to overdiagnosis and overtreatment of asymptomatic bacteriuria (ASB). Unnecessary antibiotic treatment for ASB does not improve outcomes and exposes patients to side effects. The negative implications may include […]